Literature DB >> 952717

Geographic correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece.

D Trichopoulos, G Papaevangelou, M Violaki, C Vissoulis, L Sparros, O N Manousos.   

Abstract

Average annual age-adjusted mortality rates per 100,000 from primary hepatic carcinoma (PHC) among males for 1971-1973 in the urban and rural areas of the 9 geographical regions of Greece were estimated. Hepatitis-B surface antigen (HBsAg) prevalence by region and area was evaluated in a sample of 22,844 Greek Air Force recruits from all parts of the country. Mortality from PHC was found significantly higher in urban areas (28-30 vs. 18-81) whereas prevalence of HBsAg was higher in rural areas (5-3% vs. 3-90%). Nevertheless further statistical analysis showed that there is a strong correlation between HBsAg prevalence and mortality from PHC, which is higher in rural (r = + 0-88) than in urban (+ 0-57) areas. The latter findings indicate that hepatitis B infection and PHC may be causally related.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952717      PMCID: PMC2025123          DOI: 10.1038/bjc.1976.125

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study.

Authors:  C L Vogel; P P Anthony; F Sadikali; L F Barker; M R Peterson
Journal:  J Natl Cancer Inst       Date:  1972-06       Impact factor: 13.506

2.  Geographic correlations between cancer mortality rates and alcohol-tobacco consumption in the United States.

Authors:  N E Breslow; J E Enstrom
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

3.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

4.  Risk of post-transfusion hepatitis in recepients of blood containing S.H. antigen at Harlem Hospital.

Authors:  C E Cherubin
Journal:  Lancet       Date:  1971-03-27       Impact factor: 79.321

5.  Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum.

Authors:  S Sherlock; R A Fox; S P Niazi; P J Scheuer
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

6.  Hepatitis-associated antigen in chronic liver disease.

Authors:  S J Hadziyannis; G E Merikas; A P Afroudakis
Journal:  Lancet       Date:  1970-07-11       Impact factor: 79.321

7.  Relation between blood groups and hepatitis associated antigen carrier state.

Authors:  S Hadziyannis; G Papaevangelou; C Vissoulis
Journal:  Vox Sang       Date:  1973-01       Impact factor: 2.144

8.  Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.

Authors:  P Maupas; B Werner; B Larouzé; I Millman; W T London; A O'Connell; B S Blumberg
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

9.  Letter: Epidemiology of hepatitis B and primary hepatic carcinoma.

Authors:  D Trichopoulos; M Violaki; L Sparros; E Xirouchaki
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

10.  Hepatitis and hepatoma in the tropics.

Authors:  A J Zuckerman
Journal:  Br Med J       Date:  1972-01-01
View more
  4 in total

Review 1.  Primary liver cancer and its relationship to chronic infection with the hepatitis B virus.

Authors:  S J Hadziyannis
Journal:  Springer Semin Immunopathol       Date:  1981-04

Review 2.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

3.  Hepatitis B serology in Greek prostitutes: significance of the different serum markers.

Authors:  E Kaklamani; A Kyriakidou; D Trichopoulos; G Papoutsakis; I Koumandaki; D Karalis
Journal:  J Hyg (Lond)       Date:  1980-04

4.  Serum immunoglobulins in a rural and an urban population of Greece with special reference to immunoglobulin A.

Authors:  J Economidou; O Manousos; D Trichopoulos; J Triantaphyllidis; T Tsicricas; G Merikas
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.